Document is current
Any future updates will be listed below
-
Authors
Patnaik, Sibabratta https://orcid.org/0000-0002-3020-4229
Mruthyunjaya, Prakashini https://orcid.org/0000-0002-1278-6042
Murmu, Krushna Chandra https://orcid.org/0000-0002-5568-680X
Mahapatra, Soumendu https://orcid.org/0000-0002-9304-6221
Patro, A. Raj Kumar https://orcid.org/0000-0002-6725-7148
Misra, Ramnath https://orcid.org/0000-0001-7921-4199
Pati, Sanghamitra https://orcid.org/0000-0002-7717-5592
Prasad, Punit https://orcid.org/0000-0002-9132-6078
Ahmed, Sakir https://orcid.org/0000-0003-4631-311X
-
Funding
Funding for this research was provided by:
Kalinga Institute of Industrial Technology
- License Information
-
More Information
Article History
Received: 6 July 2023
Accepted: 20 September 2023
First Online: 12 October 2023
Declarations
:
: SA has received honorarium as speaker from Cipla, Pfizer, DrReddy’s, Janssen. The other authors have no conflicts of interest to declare.
: A written informed consent was obtained from a parent or the legal guardian for all patients before inclusion into the study.
